Company Kindstar Globalgene Technology, Inc.
Equities
9960
KYG5262E1044
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.6 HKD | +2.56% | +3.90% | -4.76% |
27/03 | Kindstar Globalgene Technology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Kindstar Globalgene Arm to Setup 300 Million Yuan PE Fund | MT |
Business Summary
Number of employees: 3,125
Sales per Business
HKD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
COVID-19 Related Testing
38.7
%
| 75 | 6.7 % | 624 | 38.7 % | +733.72% |
Hematology Testing
37.9
%
| 645 | 57.5 % | 611 | 37.9 % | -5.22% |
Neurology
6.9
%
| 108 | 9.7 % | 111 | 6.9 % | +2.40% |
Routine Testing
4.1
%
| 82 | 7.3 % | 67 | 4.1 % | -18.10% |
Maternity-related Diseases
3.6
%
| 63 | 5.6 % | 58 | 3.6 % | -7.74% |
Infectious Diseases
3.4
%
| 63 | 5.6 % | 55 | 3.4 % | -11.45% |
Genetic Diseases and Rare Diseases
3.1
%
| 52 | 4.7 % | 50 | 3.1 % | -5.10% |
Oncology
1.3
%
| 10 | 0.9 % | 21 | 1.3 % | +100.17% |
Others
0.9
%
| 23 | 2.1 % | 15 | 0.9 % | -35.16% |
Sales per region
HKD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 1,122 | 100.0 % | 1,612 | 100.0 % | +43.75% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Shi Ang Huang
CEO | Chief Executive Officer | 66 | 22/11/22 |
Hai Jie Chai
DFI | Director of Finance/CFO | 46 | 04/20/04 |
Zan Bing Tu
COO | Chief Operating Officer | 52 | 04/20/04 |
Mei Yi Lee
SEC | Corporate Secretary | 56 | 15/22/15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Zuie Chin Huang
BRD | Director/Board Member | 58 | 30/12/30 |
Xin Ping Xia
BRD | Director/Board Member | 59 | 23/21/23 |
Shi Ang Huang
CEO | Chief Executive Officer | 66 | 22/11/22 |
Zan Bing Tu
COO | Chief Operating Officer | 52 | 04/20/04 |
Lu Huang
BRD | Director/Board Member | 51 | 09/20/09 |
Hua Ming Gu
BRD | Director/Board Member | 60 | 23/21/23 |
Hai Jie Chai
DFI | Director of Finance/CFO | 46 | 04/20/04 |
Wei Peng
BRD | Director/Board Member | 38 | 27/20/27 |
Shang Long Yao
BRD | Director/Board Member | 68 | 23/21/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,019,125,696 | 541,426,540 ( 53.13 %) | 32,003,000 ( 3.140 %) | 53.13 % |
Company contact information
Kindstar Globalgene Technology, Inc.
East Lake High Tech Zone 666 Gaoxin Road
430075, Wuhan
+
http://www.kindstar.com.cnSector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.76% | 195M | |
-17.89% | 8.25B | |
+39.20% | 3.57B | |
-39.11% | 2.46B | |
-8.06% | 2.46B | |
-7.35% | 2.38B | |
-12.61% | 1.81B | |
-19.01% | 1.55B | |
-40.66% | 1.21B | |
+7.56% | 1.11B |
- Stock Market
- Equities
- 9960 Stock
- Company Kindstar Globalgene Technology, Inc.